Literature DB >> 26758491

Euvesperins A and B, new circumventors of arbekacin resistance in MRSA, produced by Metarhizium sp. FKI-7236.

Mayu Shiina1, Takuya Suga1, Yukihiro Asami1,2, Kenichi Nonaka1,2, Masato Iwatsuki1,2, Satoshi Omura2, Kazuro Shiomi1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26758491     DOI： 10.1038/ja.2015.140

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  19 in total

1.  Lucilactaene, a new cell cycle inhibitor in p53-transfected cancer cells, produced by a Fusarium sp.

Authors:  H Kakeya; S Kageyama; L Nie; R Onose; G Okada; T Beppu; C J Norbury; H Osada
Journal:  J Antibiot (Tokyo)       Date:  2001-10       Impact factor: 2.649

2.  [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].

Authors:  Makiko Tabata; Masaki Shimizu; Minako Araake; Hiroshi Ogawa
Journal:  Jpn J Antibiot       Date:  2003-02

3.  Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.

Authors:  Katia Sutyak Noll; Patrick J Sinko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

4.  Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).

Authors:  Naofumi Tsuchizaki; Keiko Ishino; Fumiko Saito; Jun Ishikawa; Mutsuyasu Nakajima; Kunimoto Hotta
Journal:  J Antibiot (Tokyo)       Date:  2006-04       Impact factor: 2.649

Review 5.  Aminoglycoside resistance mediated by the bifunctional enzyme 6'-N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase.

Authors:  E Culebras; J L Martínez
Journal:  Front Biosci       Date:  1999-01-01

Review 6.  Synthetic and structure-activity relationship studies on bioactive natural products.

Authors:  Kouji Kuramochi
Journal:  Biosci Biotechnol Biochem       Date:  2013-03-07       Impact factor: 2.043

7.  Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.

Authors:  S Kondo; K Iinuma; H Yamamoto; K Maeda; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1973-07       Impact factor: 2.649

8.  Aogacillins A and B produced by Simplicillium sp. FKI-5985: new circumventors of arbekacin resistance in MRSA.

Authors:  Keiko Takata; Masato Iwatsuki; Tsuyoshi Yamamoto; Tatsuya Shirahata; Kenichi Nonaka; Rokuro Masuma; Yoichi Hayakawa; Hideaki Hanaki; Yoshinori Kobayashi; George A Petersson; Satoshi Ōmura; Kazuro Shiomi
Journal:  Org Lett       Date:  2013-09-04       Impact factor: 6.005

9.  Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications.

Authors:  S. Kondo; Kunimoto Hotta
Journal:  J Infect Chemother       Date:  1999-03       Impact factor: 2.211

Review 10.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.